Aquestive Therapeutics (AQST) Other Non-Current Liabilities (2017 - 2026)
Aquestive Therapeutics' Other Liabilities was $6.27 million in Q3 2026, up 204.6% from $2.06 million a year earlier and up 1.4% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends
At the end of FY2025, Other Liabilities at Aquestive Therapeutics came in at $7.27 million, up 203.5% from FY2024.
- Other Liabilities shows a five-year compound annual growth rate of 30.2% (FY2020 to FY2025).
- In earlier years, Other Liabilities was $2.4 million in FY2024 (+18.8%), $2.02 million in FY2023 (-0.9%), $2.03 million in FY2022 (-18.1%) and $2.49 million in FY2021 (+27.8%).
- Quarterly Other Liabilities has moved between $1.86 million (Q1 2022) and $7.27 million (Q4 2025) over five years.
- Compared with a year earlier, Other Liabilities has increased for ten straight quarters, with growth averaging 101.7% over the last eight quarters.
- The best year-over-year quarter for Other Liabilities over five years was Q3 2026 (growth of 204.6%); the worst was Q4 2022 (a decline of 18.1%).
- Per Business Quant data, AQST's Other Liabilities in the three quarters before Q3 2026 was $6.19 million (Q2 2026), $6.05 million (Q1 2026) and $7.27 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Aquestive Therapeutics | 442.42 Mn | 21.68 Mn | 3.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.27 Mn |
| Jun 30, 2026 | 6.19 Mn |
| Mar 31, 2026 | 6.05 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Sep 30, 2025 | 2.06 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | 2.40 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 2.01 Mn |
| Jun 30, 2023 | 2.01 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 2.03 Mn |
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | 2.38 Mn |
| Mar 31, 2022 | 1.86 Mn |
| Dec 31, 2021 | 2.49 Mn |
API Access
Aquestive Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();